enVVeno Medical (NVNO) Change in Accured Expenses (2017 - 2026)

enVVeno Medical's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at $15000.0 for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 103.41% year-over-year to $15000.0 in Q1 2026; TTM through Mar 2026 was $456000.0, a 208.11% increase from a year earlier, with the FY2025 full-year figure at $1000.0, down 99.86% from the prior year.
• Change in Accured Expenses climbed to $15000.0 in Q1 2026 per NVNO's latest filing, from -$382000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $1.3 million in Q2 2025 and bottomed at -$667000.0 in Q4 2023.
• The 5-year median for Change in Accured Expenses is $15000.0 (2026), against an average of $21764.7.
• Biggest YoY gain for Change in Accured Expenses was 1590.7% in 2023; the steepest drop was 605.3% in 2023.
• Year by year, Change in Accured Expenses stood at $132000.0 in 2022, then slumped by 605.3% to -$667000.0 in 2023, then soared by 78.86% to -$141000.0 in 2024, then slumped by 170.92% to -$382000.0 in 2025, then jumped by 103.93% to $15000.0 in 2026.
• Per Business Quant, the three latest NVNO Change in Accured Expenses figures stand at $15000.0 (Q1 2026), -$382000.0 (Q4 2025), and -$524000.0 (Q3 2025).